← FDA Drug Approvals (Drugs@FDA)

SENSORCAINE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: FRESENIUS KABI USA · Approved 1987-04-15

Drug application

FDA Application #

ANDA071202

Application type

Abbreviated New Drug Application (Generic)

Brand name

SENSORCAINE

Generic name

Bupivacaine Hydrochloride

Active ingredients

BUPIVACAINE HYDROCHLORIDE

Dosage form

INJECTABLE

Route

SPINAL

Marketing status

Discontinued

Sponsor

FRESENIUS KABI USA

First approval

1987-04-15

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown